EP Wealth Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.93M | Sell |
68,584
-4,951
| -7% | -$381K | 0.02% | 314 |
|
|
2025
Q4 | $5.84M | Buy |
+73,535
| New | +$5.8M | 0.03% | 253 |
|
|
2025
Q2 | $7.06M | Sell |
102,392
-4,290
| -4% | -$281K | 0.05% | 222 |
|
|
2025
Q1 | $7.23M | Buy |
106,682
+1,764
| +2% | +$106K | 0.06% | 183 |
|
|
2024
Q4 | $4.71M | Sell |
104,918
-19,416
| -16% | -$1.09M | 0.04% | 226 |
|
|
2024
Q3 | $7.82M | Sell |
124,334
-11,082
| -8% | -$647K | 0.07% | 171 |
|
|
2024
Q2 | $8M | Sell |
135,416
-473,451
| -78% | -$29.6M | 0.09% | 137 |
|
|
2024
Q1 | $48.6M | Buy |
608,867
+19,959
| +3% | +$1.52M | 0.57% | 49 |
|
|
2023
Q4 | $46.5M | Buy |
588,908
+25,001
| +4% | +$1.78M | 0.59% | 46 |
|
|
2023
Q3 | $39.4M | Buy |
563,907
+455,868
| +422% | +$32.3M | 0.61% | 41 |
|
|
2023
Q2 | $36.5M | Sell |
108,039
-16,703
| -13% | -$1.19M | 0.53% | 46 |
|
|
2023
Q1 | $154K | Sell |
124,742
-252,774
| -67% | -$21.2M | ﹤0.01% | 589 |
|
|
2022
Q4 | $35.2M | Sell |
377,516
-2,010
| -0.5% | -$194K | 0.63% | 43 |
|
|
2022
Q3 | $36.2M | Buy |
379,526
+20,335
| +6% | +$2.01M | 0.82% | 32 |
|
|
2022
Q2 | $33.3M | Sell |
359,191
-1,588
| -0.4% | -$155K | 0.75% | 37 |
|
|
2022
Q1 | $36.5M | Sell |
360,779
-7,566
| -2% | -$795K | 0.8% | 34 |
|
|
2021
Q4 | $38M | Buy |
368,345
+1,430
| +0.4% | +$132K | 0.9% | 23 |
|
|
2021
Q3 | $31.1M | Buy |
366,915
+11,875
| +3% | +$995K | 0.85% | 28 |
|
|
2021
Q2 | $29.6M | Buy |
355,040
+10,592
| +3% | +$867K | 0.82% | 27 |
|
|
2021
Q1 | $25.9M | Sell |
344,448
-35,066
| -9% | -$2.55M | 0.82% | 29 |
|
|
2020
Q4 | $25.9M | Buy |
379,514
+34,945
| +10% | +$2.27M | 0.91% | 25 |
|
|
2020
Q3 | $20.1M | Buy |
344,569
+29,235
| +9% | +$1.82M | 0.87% | 25 |
|
|
2020
Q2 | $20.5M | Buy |
315,334
+117,480
| +59% | +$7.4M | 0.87% | 24 |
|
|
2020
Q1 | $11.7M | Buy |
197,854
+11,872
| +6% | +$793K | 0.57% | 39 |
|
|
2019
Q4 | $13.8M | Buy |
185,982
+2,780
| +2% | +$195K | 0.57% | 42 |
|
|
2019
Q3 | $11.6M | Buy |
183,202
+12,239
| +7% | +$725K | 0.57% | 42 |
|
|
2019
Q2 | $9.32M | Buy |
170,963
+17,962
| +12% | +$967K | 0.58% | 39 |
|
|
2019
Q1 | $8.25M | Buy |
153,001
+2,584
| +2% | +$159K | 0.79% | 39 |
|
|
2018
Q4 | $9.86M | Buy |
150,417
+7,297
| +5% | +$545K | 0.76% | 34 |
|
|
2018
Q3 | $11.3M | Buy |
143,120
+3,957
| +3% | +$283K | 0.88% | 34 |
|
|
2018
Q2 | $8.96M | Buy |
+139,163
| New | +$9.17M | 0.84% | 35 |
|
Other funds holding CVS
VCM
VPM
EP Wealth Advisors's CVS Position: Q1 2026 in Review
EP Wealth Advisors reduced its CVS Health (CVS) stake by 6.7% in Q1 2026, selling an estimated $381K and leaving 68,584 shares worth $4.93M. The position accounts for 0.02% of the portfolio, ranked #314.
EP Wealth Advisors first reported a position in CVS in Q2 2018 and has held it in 31 quarters since. The position peaked at $48.6M in Q1 2024. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- EP Wealth Advisors held 68,584 shares of CVS Health worth $4.93M as of Q1 2026.
- EP Wealth Advisors sold 4,951 CVS Health shares in Q1 2026, an estimated $381K.
- CVS Health made up 0.02% of EP Wealth Advisors's portfolio in Q1 2026, its #314 holding.
- EP Wealth Advisors first reported a position in CVS Health in Q2 2018 and has held it in 31 quarters since.
- EP Wealth Advisors's CVS Health position peaked at $48.6M in Q1 2024.
- 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on EP Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.